| 000 | 01655 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515004929.0 | ||
| 264 | 0 | _c20060302 | |
| 008 | 200603s 0 0 eng d | ||
| 022 | _a0803-5253 | ||
| 024 | 7 |
_a10.1111/j.1651-2227.2005.tb02078.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKalkanoğlu, H Serap | |
| 245 | 0 | 0 |
_aBehavioural effects of phenylalanine-free amino acid tablet supplementation in intellectually disabled adults with untreated phenylketonuria. _h[electronic resource] |
| 260 |
_bActa paediatrica (Oslo, Norway : 1992) _cSep 2005 |
||
| 300 |
_a1218-22 p. _bdigital |
||
| 500 | _aPublication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aPersons with Disabilities |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntelligence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPhenylalanine _xtherapeutic use |
| 650 | 0 | 4 |
_aPhenylketonurias _xtherapy |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aAhring, Kirsten K | |
| 700 | 1 | _aSertkaya, Durdu | |
| 700 | 1 | _aMøller, Lisbeth Birk | |
| 700 | 1 | _aRomstad, Anne | |
| 700 | 1 | _aMikkelsen, Ingrid | |
| 700 | 1 | _aGuldberg, Per | |
| 700 | 1 | _aLou, Hans C | |
| 700 | 1 | _aGüttler, Flemming | |
| 773 | 0 |
_tActa paediatrica (Oslo, Norway : 1992) _gvol. 94 _gno. 9 _gp. 1218-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1651-2227.2005.tb02078.x _zAvailable from publisher's website |
| 999 |
_c15903845 _d15903845 |
||